Compare WTTR & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTTR | PGEN |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2017 | 2013 |
| Metric | WTTR | PGEN |
|---|---|---|
| Price | $14.01 | $3.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $16.17 | $7.67 |
| AVG Volume (30 Days) | 1.8M | ★ 4.2M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,528,930,000.00 | $230,981,000.00 |
| Revenue This Year | $2.32 | $342.78 |
| Revenue Next Year | $5.14 | $478.46 |
| P/E Ratio | $69.16 | ★ N/A |
| Revenue Growth | ★ 120.79 | N/A |
| 52 Week Low | $7.20 | $1.11 |
| 52 Week High | $15.45 | $5.47 |
| Indicator | WTTR | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 40.67 |
| Support Level | $10.10 | $3.43 |
| Resistance Level | $14.24 | $5.10 |
| Average True Range (ATR) | 0.54 | 0.21 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 85.33 | 26.50 |
Select Water Solutions Inc provides sustainable water-management solutions to the energy industry in the United States. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. The company's reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates maximum revenue from the Water Services segment, which comprises its short-cycle, field-based service offerings, including water transfer, water sourcing, fluids hauling, monitoring, containment, water-network automation, and the services associated with Peak Rentals. This segment earns revenue via market-based day rates, time-and-materials, or per-barrel delivered under MSAs and short-term work orders.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.